KBC Private Partners Life Sciences

KBC Private Partners Life Sciences is an investment fund structure domiciled in Brussel, Belgium. Funds hold LEIs in their own right, and GLEIF records who manages them rather than who owns them.

The LEI has been on record for 5 years, since 29 Apr 2021. That puts it right on the median for Belgium, where half of all LEIs date from before 2021.

The next annual re-validation is due 5 May 2027, 197 days from now.

The record has not changed since we began archiving it on 6 Jul 2026. Any future change to name, status, address, ownership or renewal date will be captured here, because GLEIF publishes only the current state and superseded values are otherwise lost.

The LEI is issued and maintained by GS1, one of the Local Operating Units accredited by GLEIF.

Beyond the LEI, 1 ISIN is mapped to this entity in the GLEIF cross-reference files.

No direct accounting-consolidating parent is reported, because no parent prepares consolidated accounts that include it. GLEIF requires this to be stated explicitly rather than left blank, so the absence is itself a data point.

No ultimate accounting-consolidating parent is reported, because no parent prepares consolidated accounts that include it. GLEIF requires this to be stated explicitly rather than left blank, so the absence is itself a data point.

The LEI registration is issued, and the entity status (active) records whether the legal entity itself still exists. The two are independent: an LEI can lapse while the company trades on, and it can stay issued after the company has been dissolved.